Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
OnMarch 11, 2020 ,Marcio Souza , Chief Operating Officer ofPTC Therapeutics, Inc. (the "Company"), notified the Company of his resignation, which is expected to be effective byApril 25, 2020 . Item 7.01. Regulation FD Disclosure. OnMarch 16, 2020 , the Company issued a press release related to the matter described above, attached hereto as Exhibit 99.1.
The information set forth in or incorporated by reference into this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. All website addresses given in this Report or incorporated herein by reference are for information only and are not intended to be an active link or to incorporate any website information into this Report. Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description Press Release, datedMarch 16, 2020 issued by PTC 99.1Therapeutics, Inc. The cover page from this Current Report on Form 8-K, 104 formatted in Inline XBRL Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
PTC Therapeutics, Inc.
Date:
Name :Emily Hill Title: Chief Financial Officer
© Edgar Online, source